A Comment on Monsanto
Become a member: Subscribe
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.

Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
No posts
A Comment on Monsanto

By Ronnie Cummins
If you put a label on genetically engineered food you might as well put a skull and crossbones on it.” – Norman Braksick, president of Asgrow Seed Co., a subsidiary of Monsanto, quoted in the Kansas City Star, March 7, 1994
“Monsanto should not have to vouchsafe the safety of biotech food. Our interest is in selling as much of it as possible. Assuring its safety is the FDA’s job.” – Phil Angell, Monsanto’s director of corporate communications, quoted in the New York Times, October 25, 1998
After 16 years of non-stop biotech bullying and force-feeding Genetically Engineered or Modified (GE or GM) crops to farm animals and “Frankenfoods” to unwitting consumers, Monsanto has a big problem, or rather several big problems.
Continue reading the article . . .
Solari Report Blog Commentaries
US Ambassador Planned “Retaliation” Against France Over Monsanto Corn Ban
(25 Dec 10)
Canadian Farmer Percy Schmeiser vs Monsanto
(20 Sept 10)
Related reading:
The Millions Against Monsanto Campaign
Organic Consumers Association
Our mission is to help you live a free and inspired life. This includes building wealth in ways that build real wealth in the wider economy. We believe that personal and family wealth is a critical ingredient of both individual freedom and community, health and well-being.
Nothing on The Solari Report should be taken as individual investment, legal, or medical advice. Anyone seeking investment, legal, medical, or other professional advice for his or her personal situation is advised to seek out a qualified advisor or advisors and provide as much information as possible to the advisor in order that such advisor can take into account all relevant circumstances, objectives, and risks before rendering an opinion as to the appropriate strategy.
Be the first to know about new articles, series and events.
